ZFP36

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ZFP36 mutation is significantly associated with the drug of many other genes, with 40 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ZFP36-associated genes across cancer lineages are Lapatinib, CI-1040, and AZD8055. Each is linked with ZFP36 in more than 1 cancer types. Because this analysis shows association rather than direction, both ZFP36-to-partner and partner-to-ZFP36 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, Lapatinib grouped by ZFP36-low versus ZFP36-high in BLOOD_Leukemia.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZFP36→partner) and Y-score (partner→ZFP36) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LeukemiaLapatinib →+0.238+2.655.042.04432
BLOOD_LeukemiaCI-1040 →-0.521-2.283.028.02431
BLOOD_LeukemiaAZD8055 →-0.532-3.278<.001.00331
BLOOD_LeukemiaThapsigargin →+0.414+2.667.048.04031
BLOOD_LeukemiaUlixertinib →-0.289-2.807.042.04931
BLOOD_LeukemiaWZ-1-84 →+0.274+3.321.038.00631
Each partner links to its Q-omics profile. Showing the 6 strongest of 40 associations by consensus.

Lapatinib by ZFP36 expression — BLOOD_Leukemia

Box plot of Lapatinib in ZFP36-low vs ZFP36-high samples in BLOOD_Leukemia.

Explore this box plot interactively →

Exploration